These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37392953)

  • 21. The OLGA-OLGIM staging and the interobserver agreement for gastritis and preneoplastic lesion screening: a cross-sectional study.
    Salazar BE; Pérez-Cala T; Gomez-Villegas SI; Cardona-Zapata L; Pazos-Bastidas S; Cardona-Estepa A; Vélez-Gómez DE; Justinico-Castro JA; Bernal-Cobo A; Dávila-Giraldo HA; Benítez-Guerra JC; Valencia-Cárdenas JT; Ospina EJ; Castaño-Llano R; Bravo MM; Cataño-Correa JC; Zabaleta J; Trespalacios-Rangel AA; Cock-Botero AM; Roldán-Pérez MI; Martínez A
    Virchows Arch; 2022 Apr; 480(4):759-769. PubMed ID: 35089403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
    Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
    Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review.
    Spence AD; Cardwell CR; McMenamin ÚC; Hicks BM; Johnston BT; Murray LJ; Coleman HG
    BMC Gastroenterol; 2017 Dec; 17(1):157. PubMed ID: 29228909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incomplete Intestinal Metaplasia Is Rare in Autoimmune Gastritis.
    Genta RM; Turner KO; Robiou C; Singhal A; Rugge M
    Dig Dis; 2023; 41(3):369-376. PubMed ID: 36739859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.
    De Re V; Orzes E; Canzonieri V; Maiero S; Fornasarig M; Alessandrini L; Cervo S; Steffan A; Zanette G; Mazzon C; De Paoli P; Cannizzaro R
    Clin Transl Gastroenterol; 2016 Jul; 7(7):e183. PubMed ID: 27441820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP.
    Cubiella J; Pérez Aisa Á; Cuatrecasas M; Díez Redondo P; Fernández Esparrach G; Marín-Gabriel JC; Moreira L; Núñez H; Pardo López ML; Rodríguez de Santiago E; Rosón P; Sanz Anquela JM; Calvet X;
    Gastroenterol Hepatol; 2021 Jan; 44(1):67-86. PubMed ID: 33252332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer.
    Zhang C; Yamada N; Wu YL; Wen M; Matsuhisa T; Matsukura N
    World J Gastroenterol; 2005 Feb; 11(6):791-6. PubMed ID: 15682469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The accuracy of flexible spectral imaging colour enhancement for the diagnosis of gastric intestinal metaplasia: do we still need histology to select individuals at risk for adenocarcinoma?
    Kikuste I; Stirna D; Liepniece-Karele I; Leja M; Dinis-Ribeiro M
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):704-9. PubMed ID: 24901816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
    Liu KS; Wong IO; Leung WK
    World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Gastritis and Gastric Cancer Risk in the Chilean Population Using the OLGA System.
    Bellolio E; Riquelme I; Riffo-Campos AL; Rueda C; Ferreccio C; Villaseca M; Brebi P; Muñoz S; Araya JC
    Pathol Oncol Res; 2019 Jul; 25(3):1135-1142. PubMed ID: 30467699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration.
    Sakitani K; Hirata Y; Watabe H; Yamada A; Sugimoto T; Yamaji Y; Yoshida H; Maeda S; Omata M; Koike K
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1570-5. PubMed ID: 21575058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incomplete intestinal metaplasia as an indicator for early detection of gastric carcinoma in the events of helicobacter pylori positive chronic atrophic gastritis.
    Vukobrat-Bijedić Z; Radović S; Husić-Selimović A; Gornjaković S
    Bosn J Basic Med Sci; 2006 Nov; 6(4):48-53. PubMed ID: 17177650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OLGA- and OLGIM-Based Staging in the Patients with Gastritis and Endoscopy Indications.
    Mansour-Ghanaei F; Joukar F; Yeganeh S; Sadeghi M; Daryakar A; Sepehrimanesh M
    Turk J Gastroenterol; 2022 Feb; 33(2):95-102. PubMed ID: 35238779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoscopic and histological risk stratification for gastric cancer using gastric intestinal metaplasia.
    Kawamura M; Uedo N; Yao K; Koike T; Kanesaka T; Hatta W; Ogata Y; Iwai W; Yokosawa S; Honda J; Asonuma S; Okata H; Ohyauchi M; Ito H; Abe Y; Ara N; Kayaba S; Shinkai H; Kanemitsu T
    J Gastroenterol Hepatol; 2024 Sep; 39(9):1910-1916. PubMed ID: 38740510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence.
    González CA; Sanz-Anquela JM; Gisbert JP; Correa P
    Int J Cancer; 2013 Sep; 133(5):1023-32. PubMed ID: 23280711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population.
    Nam JH; Choi IJ; Kook MC; Lee JY; Cho SJ; Nam SY; Kim CG
    Helicobacter; 2014 Apr; 19(2):81-9. PubMed ID: 24617667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal metaplasia of the gastric cardia.
    Morales TG; Sampliner RE; Bhattacharyya A
    Am J Gastroenterol; 1997 Mar; 92(3):414-8. PubMed ID: 9068460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area.
    Chapelle N; Péron M; Quénéhervé L; Bourget A; Leroy M; Touchefeu Y; Cauchin E; Coron E; Mosnier JF; Matysiak-Budnik T
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00237. PubMed ID: 33512802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastric atrophy and extent of intestinal metaplasia in a cohort of Helicobacter pylori-infected patients.
    Guarner J; Herrera-Goepfert R; Mohar A; Sanchez L; Halperin D; Ley C; Parsonnet J
    Hum Pathol; 2001 Jan; 32(1):31-5. PubMed ID: 11172292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.